CN101213164A - 二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途 - Google Patents

二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途 Download PDF

Info

Publication number
CN101213164A
CN101213164A CNA2006800014830A CN200680001483A CN101213164A CN 101213164 A CN101213164 A CN 101213164A CN A2006800014830 A CNA2006800014830 A CN A2006800014830A CN 200680001483 A CN200680001483 A CN 200680001483A CN 101213164 A CN101213164 A CN 101213164A
Authority
CN
China
Prior art keywords
methoxyl group
naphthalenes
dihydros
methylol
aldehyde radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006800014830A
Other languages
English (en)
Other versions
CN101213164B (zh
Inventor
周应军
史跃年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darui Technology Investment Co ltd
Central South University
Original Assignee
Darui Technology Investment Co ltd
Central South University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darui Technology Investment Co ltd, Central South University filed Critical Darui Technology Investment Co ltd
Priority to CN2006800014830A priority Critical patent/CN101213164B/zh
Publication of CN101213164A publication Critical patent/CN101213164A/zh
Application granted granted Critical
Publication of CN101213164B publication Critical patent/CN101213164B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/577—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/47—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

一种具有Akt抑制活性的如下通式的芳基二氢萘类木脂素衍生物，以及该化合物和含有该化合物的药物组合物通过抑制Akt活性通路治疗癌症的方法。其中，X为C＝O、C＝S、C＝N、亚甲基或烯基；Y是氢原子、羟基、氨基、烷基或没有Y基团；R1、R2分别为氢原子、烷基、烯基、葡萄糖基、葡萄糖醛酸基、酰基或芳基；R3为氢原子或葡萄糖基；R4为甲氧基或氢原子；R5为甲氧基或氢原子；母核中三位和四位的氢为(3R，4S)。

Description

PCT国内申请，说明书已公开。

Claims (1)

  1. PCT国内申请，权利要求书已公开。
CN2006800014830A 2005-12-30 2006-12-30 二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途 Expired - Fee Related CN101213164B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006800014830A CN101213164B (zh) 2005-12-30 2006-12-30 二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CNA2005101366567A CN1990445A (zh) 2005-12-30 2005-12-30 芳基二氢萘类木脂素衍生物及其用途
CN200510136656.7 2005-12-30
CN2006800014830A CN101213164B (zh) 2005-12-30 2006-12-30 二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途
PCT/CN2006/003703 WO2007076704A1 (fr) 2005-12-30 2006-12-30 COMPOSÉS DE DIHYDRO-NAPHTALÈNE D'ARYLE, LEUR PRÉPARATION ET LEUR UTILISATION COMME INHIBITEUR D'Akt POUR LA PRÉVENTION ET LE TRAITEMENT DU CANCER

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2010101813646A Division CN101972267B (zh) 2005-12-30 2006-12-30 二氢芳基萘类化合物在制备治疗与预防肿瘤药物中的用途

Publications (2)

Publication Number Publication Date
CN101213164A true CN101213164A (zh) 2008-07-02
CN101213164B CN101213164B (zh) 2011-06-22

Family

ID=38213017

Family Applications (3)

Application Number Title Priority Date Filing Date
CNA2005101366567A Pending CN1990445A (zh) 2005-12-30 2005-12-30 芳基二氢萘类木脂素衍生物及其用途
CN2010101813646A Expired - Fee Related CN101972267B (zh) 2005-12-30 2006-12-30 二氢芳基萘类化合物在制备治疗与预防肿瘤药物中的用途
CN2006800014830A Expired - Fee Related CN101213164B (zh) 2005-12-30 2006-12-30 二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CNA2005101366567A Pending CN1990445A (zh) 2005-12-30 2005-12-30 芳基二氢萘类木脂素衍生物及其用途
CN2010101813646A Expired - Fee Related CN101972267B (zh) 2005-12-30 2006-12-30 二氢芳基萘类化合物在制备治疗与预防肿瘤药物中的用途

Country Status (4)

Country Link
EP (1) EP1972611A1 (zh)
JP (1) JP2009522212A (zh)
CN (3) CN1990445A (zh)
WO (1) WO2007076704A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114262270A (zh) * 2022-01-10 2022-04-01 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种芳基二氢萘木脂素类化合物及其制备方法以及应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102258502B (zh) * 2010-05-28 2015-05-06 中南大学 二氢芳基萘类木脂素衍生物及其组合物用于制备预防和治疗乳腺增生药物的应用
CN102349886B (zh) * 2011-07-05 2013-04-24 中国人民解放军第二军医大学 苯代萘型木脂素类化合物在制备抗辐射药物中的应用
CN103127159A (zh) * 2013-02-05 2013-06-05 广西壮族自治区药用植物园 一种芳基萘型木脂素在治疗丙型病毒性肝炎(hcv)中的应用
CN103467463B (zh) * 2013-09-18 2016-06-22 南开大学 一类木脂素类衍生物及其制备方法和用途
CN104447364B (zh) * 2013-09-18 2017-05-17 中南大学 4`‑位氮烷基取代二氢芳基萘类木脂素化合物及其在制备治疗与预防肿瘤药物中的应用
CN103860528A (zh) * 2014-01-21 2014-06-18 中国人民解放军第二军医大学 一种芳基萘型木脂素在制备抗前列腺癌药物中的应用
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
CN110563781B (zh) * 2019-09-30 2021-06-25 江南大学 一种合欢皮新木脂体单体化合物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284789B1 (en) * 1998-09-04 2001-09-04 The Research Foundation Of State University Of New York Formation and composition of new optically active compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114262270A (zh) * 2022-01-10 2022-04-01 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种芳基二氢萘木脂素类化合物及其制备方法以及应用
CN114262270B (zh) * 2022-01-10 2023-07-07 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种芳基二氢萘木脂素类化合物及其制备方法以及应用

Also Published As

Publication number Publication date
CN101213164B (zh) 2011-06-22
WO2007076704A1 (fr) 2007-07-12
CN1990445A (zh) 2007-07-04
CN101972267A (zh) 2011-02-16
JP2009522212A (ja) 2009-06-11
EP1972611A1 (en) 2008-09-24
CN101972267B (zh) 2012-09-05

Similar Documents

Publication Publication Date Title
CN101213164A (zh) 二氢芳基萘类化合物，制备方法以及作为Akt抑制剂预防与治疗癌症的用途
CA2304770C (en) A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds
Rao et al. Differential effects of synthesized 2′-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution
Vue et al. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations
CN109134586B (zh) 雷公藤红素衍生物及其应用
JP2009280610A (ja) 腫瘍／癌細胞の増殖の抑制活性を有するガンボージ樹脂から単離した化合物及びその化合物を含む薬学的組成物
EP1976533A2 (en) Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
CN103665082B (zh) 雪胆葫芦烷型四环三萜化合物,含有该化合物的药物组合物及其应用
JP4787752B2 (ja) ウィタナミド及びウィタノリド組成物及びその使用法
Su et al. Artematrovirenins A–P, guaiane-type sesquiterpenoids with cytotoxicities against two hepatoma cell lines from Artemisia atrovirens
Zheng et al. Cytotoxic guaianolides and seco-guaianolides from Artemisia atrovirens
CN103626824B (zh) 一种雪胆葫芦烷型四环三萜化合物,含有该化合物的药物组合物及其应用
Mironov et al. 6-(4′-Aryl-1′, 2′, 3′-triazolyl)-spirostan-3, 5-diols and 6-(4′-Aryl-1′, 2′, 3′-triazolyl)-7-hydroxyspirosta-1, 4-dien-3-ones: Synthesis and analysis of their cytotoxicity
US20040024055A1 (en) Pharmaceutical composition containing the exract of saururus chinensis baill useful as an anticancer agent and a process for the preparation thereof
CN100357264C (zh) 一种查尔酮肟及其组合物、制备方法和应用
JP3848158B2 (ja) 新規のキサントン化合物、その製造および医薬としての使用
CN109897022B (zh) 含笑内酯衍生物、其药物组合物及其制备方法和用途
JP2009511436A (ja) フタリド誘導体の使用
CN106188211B (zh) 白桦脂酸衍生物及其应用
WO2001023384A1 (fr) Agents antitumoraux
CN111217825B (zh) 4-o-氨丙基土甘草a衍生物及其制备及应用
Zhen et al. Artemdubinoids A–N: novel sesquiterpenoids with antihepatoma cytotoxicity from Artemisia dubia
CN104334571B (zh) 重楼皂苷i的酰化衍生物、及其制备方法和应用
TW200827332A (en) Aryldihydronnaphthalenes as Akt inhibitor for cancer prevention and treatment, and a process for producing same
CN111995647B (zh) 从绿萼梅中分离的具有抗肿瘤活性的化合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110622

Termination date: 20151230

EXPY Termination of patent right or utility model